期刊文献+

促进乳头状瘤病毒L1蛋白表达和DNA疫苗免疫效应的研究

Enhancement of papillomavirus L1 gene expression and the immune responses of DNA vaccine and its mechanisms
原文传递
导出
摘要 目的探讨促进乳头状瘤病毒(PV)晚期基因L1的蛋白表达和DNA疫苗免疫效应的途径及可能的机制。方法分别将含人源化优化密码BPVL1-GFP融合基因(HL1-GFP)和野生型BPVL1-GFP融合基因(WL1-GFP)的真核表达质粒体外单独转染或与tRNAser真核表达质粒共转染人角质形成细胞HaCAT,荧光显微镜及Western blot方法观察L1-GFP融合蛋白的瞬时表达情况。半定量RT-PCR分析不同PV L1基因mRNA的表达。BALB/c小鼠股四头肌内分别接种野生型、优化密码L1 DNA疫苗,同时将L1 DNA疫苗与tRNAser真核表达质粒混合后接种小鼠,观察诱导产生的体液免疫反应。结果野生型WL1-GFP融合基因在HaCAT细胞中未能有效表达,优化密码HL1-GFP基因在HaCAT细胞中的蛋白表达水平明显增强;但两者在mRNA水平差异无统计学意义。WL1-GFP与tRNAser真核表达质粒共转染细胞中L1蛋白的表达较单独转染WL1-GFP基因时增强。动物DNA免疫结果表明,优化密码HL1 DNA疫苗接种可使小鼠特异性L1中和抗体水平明显升高;而野生型WL1 DNA疫苗接种组小鼠仅产生低滴度的L1抗体,WL1 DNA疫苗与tRNAser真核表达质粒混合接种使小鼠的L1抗体水平增加。结论优化密码能显著促进乳头状瘤病毒晚期基因L1在哺乳动物细胞中的表达和DNA疫苗的免疫反应;补充外源tRNAser基因能够提高野生型L1基因的蛋白表达和DNA疫苗诱导的体液免疫应答。 Objective To explore the approaches and the possible mechanisms of the papillomavirus (PV) L 1 gene expression and the immune responses of DNA vaccinations. Methods Recombinant eukaryotic expression vectors containing codon optimized BPVL1-GFP (HL1-GFP) fusion gene and wild type BPVL1-GFP (WL1-GFP) fusion gene transfected HaCAT cells alone or cotransfected with pSVtRNA^ser separately. The transient expressions of the fusion proteins were examined by fluorescence microscopy and Western blot method. Message RNA expression of different L1 genes was measured by semi-quantitative RT-PCR. For in vivo studies, some female BALB/c mice were immunized intramuscularly with wild-type and codon modified L1 DNA vaccine individually, meanwhile, some other female BALB/c mice were immunized with the combination of pSVtRNA^ser and L1 DNA vaccine. Results Fluorescence microscopy and Western blot results showed that HL1-GFP gene readily expressed in HaCAT cells, while WL1-GFP gene failed to express. Semi-quantitative RT-PCR suggested that there was no significant difference in mRNA expression levels between HL1 and WL1 genes. Cells cotransfected with pSVtRNA^ser and WL1-GFP gene produced higher levels of L1 protein than those transfected with WL1 gene only. In vivo study results indicated that mice immunized with HL1 DNA vaccination elicited significantly higher levels of Ll-specific serum IgG than those with WL1 immunization. The mice immunized with tRNA^ser and WL1 gene produced higher IgG antibody level than those with WL1 immunization only. Condusion Codon usage optimization can significantly enhance PV L1 protein expression in mammalian cells and the humoral immune response of DNA vaccine, and supplementation of exogenous tRNA can also promote wild-type L1 protein expression in mammalian cells and the humoral immune response.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2006年第6期516-520,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金(30271193 30470086) 山东省自然科学基金(Y2002004)
关键词 乳头状瘤病毒 L1基因 TRNA 蛋白表达 DNA免疫 Papillomaviras L1 gene tRNA Protein expression DNA immunization
  • 相关文献

参考文献16

  • 1Lowy DR,Frazer IH.Prophylactic human papillomavirus vaccines.J Natl Cancer Inst Monogr,2003,31:111-116.
  • 2Ohlschlager P,Osen W,Dell K,et al.Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regreasion in C57BL/6 mice.J Virol,2003,77(8):4635-4645.
  • 3Moore RA,Santos EB,Nicholls PK,et al.Intraepithelial DNA immunization with a plasmid encoding a codon optimised COPV E1 gene sequence,but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beagles.Virol,2002,304(2):451-459.
  • 4Leder C,Kleinschmidt JA,Wiethe C,et al.Enhancement of capsid gene expression:preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.J Virol,2001,75(19):9201-9209.
  • 5Zhou J,Liu WJ,Peng SW,et al.Papillomavirus capid protein express level depends on the match between codon usage and tRNA availability.J Virol,1999,73:4972-4982.
  • 6Ramakrishna L,Anand KK,Mohankumar KM,et al.Codon optimization of the Tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.J Virol,2004,78(17):9174-9189.
  • 7王红,赵蔚明,周亚滨,贾继辉,孙建芝,于修平.人源化BPVL1-GFP融合基因的构建以及在哺乳动物细胞中的瞬时表达[J].山东大学学报(医学版),2003,41(6):600-603. 被引量:2
  • 8赵蔚明,卜淑蕊,王红,刘文军,于修平.外源性tRNAser对人乳头瘤病毒E7基因表达的影响[J].山东大学学报(医学版),2004,42(1):5-8. 被引量:1
  • 9Liu WJ,Gao F,2hao KN,et al.Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity.Virol,2002,301 (1):43-52.
  • 10Mossadegh N,Gissmann L,Muller M,et al.Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.Virol,2004,326(1):57-66.

二级参考文献13

  • 1Liu WJ, Gao F, Zhao KN, et al, Codon modified human papillomavirus type 16 E7 DNA vaccineenhances cytotoxic T-lymphocyte induction and antitumour activity[J]. Virology, 2002, 301:43.
  • 2Lund AH, Schmitz A, Pedersen FS, et al. Identification of a novel human tRNAser (CGA) functional in murine Leukemia virus replication [J]. Biochimica et Biophysica Acta 2000,1492:264.
  • 3Frazer IH. Strategies for immunoprophylaxis and immunotherapy of papillomaviruses [J]. Clin Dermatol, 1997,15:285.
  • 4Zhou J, Liu W J, Peng SW, et al. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability [J]. J Virol,1999, 73:4972.
  • 5Stoler MH, Rhodes CR, Whitbeck A, et al. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias[J]. Hum. Pathol, 1992, 23:117
  • 6Dem L, Bojak A, Steck S, et al. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein[J]. J Virol, 2001, 75(22):10991
  • 7Leder C, Kleinschmidt JA, Wiethe C,et al. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes[J]. J Virol,2001, 75(19): 9201
  • 8Strauss EG, Strauss JH, Levine AJ. Virus evolution[J].Virology, 1995:153
  • 9Zur Megede J, Chen MC, Doe B, et al. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene [J].J Virol, 2000, 74(6): 2628
  • 10Yang TT, Cheng LZ, Kain SR, et al. Optimized codon usage and chromophore mutations provide enhanced sensitivity with thegreen fluorescent protein[J]. Nuclic Acids Res, 1996,24:4592

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部